SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending amidst a perfect storm of positive developments, including a new European distribution partnership and FDA submissions, intensifying community anticipation of a significant short squeeze fueled by exceptionally high short interest and active options trading.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

The FDA's unexpected reversal to review Moderna's seasonal flu vaccine application, after an initial refusal, is propelling the stock higher, leading to widespread community discussion of a significant short squeeze and optimism for its broader mRNA pipeline.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to investor anticipation of the imminent BLA resubmission for its Duchenne muscular dystrophy therapy, Deramiocel, with strong Phase 3 data. The community is actively discussing increasing institutional interest and potential for significant upside as the company progresses with regulatory approvals and advances its exosome-based StealthX platform.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending after reporting a net loss despite strong revenue and gross merchandise volume growth, primarily driven by increased loan loss provisions, sparking community debate over the sustainability of its Buy Now, Pay Later model and its current valuation.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is captivating the market ahead of its NYSE Opening Bell ceremony, with community chatter centered on a potential short squeeze fueled by its tight share float and high borrow fees, alongside broader interest in the space sector and defense-related news.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is trending following its strong Q4 earnings beat, rapid store expansion plans, and new retail product rollout, further bolstered by its S&P MidCap 400 inclusion, even as its premium valuation fuels intense debate and volatile trading among investors.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending after its Q4 earnings beat and a significant new share buyback program, with community discussion polarized by its cautious outlook and high valuation relative to competitors.

Deere & Co. engages in the manufacture and distribution of equipment used in agriculture, construction, forestry, and turf care. It operates through the following segments: Agriculture and Turf, Construction and Forestry, and Financial Services. The Agriculture and Turf segment focuses on the distribution and manufacture of a full line of agriculture and turf equipment and related service parts. The Construction and Forestry segment offers machines and service parts used in construction, earthmoving, road building, material handling and timber harvesting. The Financial Services segment finances sales and leases by John Deere dealers of new and used agriculture and turf equipment and construction and forestry equipment. The company was founded by John Deere in 1837 and is headquartered in Moline, IL.

Deere & Co.

Deere & Co

Deere & Co is surging after exceeding earnings expectations and boosting its full-year outlook, with management signaling a bottom in the agricultural cycle driven by strong construction and small agriculture segments. While bulls celebrate the "monster run" and anticipate further analyst upgrades, a divided community expresses strong skepticism, citing "overvalued" fundamentals and "pure pump" action amid concerns over declining revenue and farmer spending.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is experiencing significant buzz following a strong Q4 earnings beat, positive Q1 guidance, and the strategic acquisition of Depop from Etsy to bolster its Gen Z recommerce strategy. The community is actively discussing its potential for sustained growth and a re-rating, with analysts noting operating momentum and a new share buyback.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeer Technologies is experiencing high volatility and a significant price drop after announcing dilutive offerings to fund its AI and high-performance computing data center expansion, further impacted by a recent fire at its Ohio development site. While many express concern over the dilution and ongoing legal challenges, a segment of the community views the sharp sell-off as an overreaction, highlighting analyst upgrades and the company's long-term growth prospects in the AI infrastructure sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS $ABBV We are seeing Near Miraculous Survival in this Phase 3 AML trial for Second Remission CR2 Patients who are -- NOT ELIGIBLE for Transplant. 
 
- not sure if you realize, these are CR2 AML Patients, having gone through debilitating Intensive Chemo (7+3), the Salvage, w more Chemo and or Ven +Aza - 
- Very Toxic Drugs 
- 25% of the VIALE-A Newly Diagnosed Patients taking AZA+VEN, DIED FROM TAKING AZA+VEN  
- 99% Severe Grade 3 or Higher Side Effects, and these CR2 Patients in the REGAL Phase 3 are NOT ELIGIBLE for Transplant - many of which is likely due to Co-morbidities, which by definition, will reduce life expectancy greatly for these patients.

Keith Thompson

Jesse101

GreyLock

Wayne

Tony M

Shultzy

Thadeus

The Wolf of Finland

Louis

Nightrite99

Stephen

$SLS While we are seeing Near Miraculous Survival in ALL POOLED REGAL Phase 3 Patients  
- (ALL Pooled = GPS Treatment and BAT Control arms Combined.) BAT ie. Aza+VEN Has FAILED 3 Large Phase 3 Trials.   
   
SLS is the Investment Opportunity of a Lifetime 
 
The Positive P3 Registrational Result is worth $40B to Big Pharma.   
The share price will continue Climbing all along the Approach to the Final Analysis and then the Share Price Absolutely Launches.   
  
 -- and we are officially in the ANY DAY NOW Zone.   
  
- ALL P3 patients are IN TRIAL for Nearly 24 months   
- 3 Months longer than the GPS Phase 2 Median OS of 21 months - all things being equal we should have seen at least 30+ GPS P3 Patient Events . and . we Know there have been +/- 60 Events Already from the Control Arm.

StockTwits Web

SELLAS Life Sciences Group Inc

6,700% ROI this quarter

Abbvie Inc

 We are seeing Near Miraculous Survival in this Phase 3 AML trial for Second Remission CR2 Patients who are -- NOT ELIGIBLE for Transplant. 
 
- not sure if you realize, these are CR2 AML Patients, having gone through debilitating Intensive Chemo (7+3), the Salvage, w more Chemo and or Ven +Aza - 
- Very Toxic Drugs 
- 25% of the VIALE-A Newly Diagnosed Patients taking AZA+VEN, DIED FROM TAKING AZA+VEN  
- 99% Severe Grade 3 or Higher Side Effects, and these CR2 Patients in the REGAL Phase 3 are NOT ELIGIBLE for Transplant - many of which is likely due to Co-morbidities, which by definition, will reduce life expectancy greatly for these patients.

Merck & Co Inc

Pfizer Inc

SPDR S&P Biotech ETF

Forty Seven, Inc.

Abivax - ADR

@67X_ROI_Q1_2026 i am more than bullish, in fact, all in. Did a ton of DD with highest conviction ever. I am just wondering in case of relapse in the BAT arm, protocol changes, another salvage (in case eligible modern Menin inhibitors) and thereafter free to maintain with Onureg? Any thought? Appreciate your expert view

StockTwits For Android 

 i am more than bullish, in fact, all in. Did a ton of DD with highest conviction ever. I am just wondering in case of relapse in the BAT arm, protocol changes, another salvage (in case eligible modern Menin inhibitors) and thereafter free to maintain with Onureg? Any thought? Appreciate your expert view

Atossa Therapeutics Inc

Zevra Therapeutics Inc

Vyome Holdings Inc.

Damir

@Badolo83 / interesting question: revumenib/ziftomenib fda approval occurred dec/Jan 2024 ? -- /  
I note, because REGAL precludes patients who are able to be treated with targeted agents - so, they should not be in the numbers??  
- onureg was available treatment from the start of regal.

 / interesting question: revumenib/ziftomenib fda approval occurred dec/Jan 2024 ? -- /  
I note, because REGAL precludes patients who are able to be treated with targeted agents - so, they should not be in the numbers??  
- onureg was available treatment from the start of regal.